InvestorsHub Logo
Followers 73
Posts 6212
Boards Moderated 0
Alias Born 05/01/2011

Re: JRoon71 post# 397890

Thursday, 01/12/2023 11:32:08 AM

Thursday, January 12, 2023 11:32:08 AM

Post# of 425915
It is absolutely true that we do not definitively know his plan here. All we know is his history, and his statements.

The history is a pretty strong indicator, however. M&A is his go-to approach. "Among Sarissa’s successful investments were Idenix, which was sold to Merck for $3.85 billion, ARIAD Pharmaceuticals, which was acquired by Takeda Pharmaceutical Co for $62 billion, and Bioverativ, which was spun off from Biogen and then sold to Sanofi SA for $11.6 billion." And there are others.

When you combine that history with the blunt fact that GIA is the Road to Hell for this one-drug company with no real game plan, it's not a big stretch to think the plan is to sell this turd.

"The biggest obstacles to our progress exist within our own lives in the form of cowardice and the tendency to give up. Breaking through these barriers will unleash a surging wave of change." -- Daisaku Ikeda

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News